Ethyl 1-cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate, 250mg

Ethyl 2-bromoindolizine-7-carboxylate, 100mg

tert-Butyl 3,3-dimethylpiperazine-1-carboxylate hydrochloride, 97%, 250mg

Acide tungstophosphorique hydraté, pa, cristallisé, 500 g, emballage verre

Incubateur à CO2 série ICO version Plus avec contrôle actif de l'humidification et de la déshumidification, 241 l, ICO240 Plus, 1 pièce

N,N-dimethyl-7-(piperazin-1-yl)benzo[c][1,2,5]oxadiazole-4-sulfonamide, 98%, 10mg

(3-Chloropyridin-4-yl)methanol, 97.0%, 250mg

Methyl 5-bromo-6-cyanopicolinate, 95.0%, 250mg

(R)-2-PHENYLPIPERIDINE, 95.0%, 10g

7-Hydroxy-2H-benzo[b][1,4]thiazin-3(4H)-one, 98%, 500mg

N-((1H-IMIDAZOL-5-YL)METHYL)-1-PHENYLMETHANAMINE HCL, 95.0%, 2g

Colonne capillaire GC ROTI®Cap-1, 60 m, 0,32 mm, 1,00 µm, 1 pièce(s)

n-(3,5-Dichlorobenzyl)cyclopropanamine, 95%, 250mg